Annexon (NASDAQ:ANNX) highlighted progress across three programs targeting the classical complement pathway during a fireside chat at TD Cowen’s 46th Annual Healthcare Conference, with President and ...
Lead antibody MB0109 targets C1q and uniquely inhibits both classical complement cascade and C1q-mediated macrophage/microglial activation — two key drivers of neuroinflammationMB0109 demonstrated ...
Creative Biolabs expands its research capabilities, offering diversified tools and services to support global biomedical innovation. SHIRLEY, NY, UNITED STATES, February 27, 2026 /EINPresswire.com/ — ...
Market expansion in med derm cross over: Almirall’s Seysara (sarecycline) won NMPA approval for moderate to severe acne (≥9 years), with China commercial launch targeted for 2026 – relevant to ...
Supa Nova by Chanté Timothy, a graphic novel about a young Black girl with a love for science, won the children’s fiction category and inaugural children’s choice prize ...
A replay of the webcast will be archived on the Annexon website for 30 days following the presentation. Annexon Biosciences (Nasdaq: ANNX) is advancing the next generation platform of targeted ...
Chennai: People whose immune systems mount an unusually aggressive early response to tuberculosis may be less likely to respond well to standard drug .
Wander a perfectly preserved Georgia estate where grand rooms, lush grounds, and timeless Southern elegance transport ...
Opportunities in the C5 inhibitors market include developing next-gen biosimilars and biosuperiors to improve administration frequency and expand treatment indications for diseases like aHUS, SCD, MG, ...
Europe has strengthened its push for technological sovereignty with the launch of the Euro Q Exa quantum computing system in Munich, marking a significant addition to the continent’s developing ...
-- The unmet need and current treatment landscape for GA -- The mechanism of disease and role of C1q -- Vonaprument, Annexon's neuroprotective C1q inhibitor with the potential to be the first targeted ...
Readers discuss ways to rescue the industry. To the Editor: Re “Stop Mutilating Classical Music to Sell It to Kids,” by Evan Shinners (Opinion guest essay, Jan. 23): Mr. Shinners’s essay makes an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results